Clinical Safety and Pharmacokinetics of FMX101 4% Topical Minocycline Foam in Pediatric Patients for the Treatment of Moderate-to-Severe Acne Vulgaris. J of Skin 2019, 3, S2. https://doi.org/10.25251/skin.3.supp.2.